Brian C. Gilger
About
In The Last Decade
Brian C. Gilger
218 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 118
- Ophthalmology 2.0k
- Radiology, Nuclear Medicine and Imaging 1.4k
- Public Health, Environmental and Occupational Health 1.1k
- Molecular Biology 870
- Epidemiology 486
Countries citing papers authored by Brian C. Gilger
This map shows the geographic impact of Brian C. Gilger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian C. Gilger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian C. Gilger more than expected).
Fields of papers citing papers by Brian C. Gilger
This network shows the impact of papers produced by Brian C. Gilger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian C. Gilger. The network helps show where Brian C. Gilger may publish in the future.
Co-authorship network of co-authors of Brian C. Gilger
This figure shows the co-authorship network connecting the top 25 collaborators of Brian C. Gilger. A scholar is included among the top collaborators of Brian C. Gilger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian C. Gilger. Brian C. Gilger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Intracorneal sequential dosing of AAV-ArsB clears corneal opacity associated with mucopolysaccharidosis VI in a feline model | 2 |
| 3 | Prevention of experimental autoimmune uveitis by intravitreal AAV-EqIL-10 | 3 |
| 4 | 0 | |
| 5 | AAV vector-mediated HLA-G expression to prevent corneal transplant rejection | 3 |
| 6 | Modifications of Sunitinib-Loaded GB-102 Microparticles that Lengthen Drug Release: 9-Months Ocular Tolerability and PK in Rabbit Following IVT Dosing | 2 |
| 7 | Evaluation of Aflibercept in a Laser-Induced Model of Choroidal Neovascularization in Pigs | 1 |
| 8 | Intracameral Conversion of Travoprost to Travoprost Acid in the Normotensive Beagle Dog Model | 2 |
| 9 | Treatment of Acute Posterior Uveitis by Injection of Triamcinolone Acetonide into the Suprachoroidal Space Using Microneedles | 1 |
| 10 | SCY-641 - A Water-Soluble Cyclophilin Inhibitor for the Treatment of Dry Eye Disease | 2 |
| 11 | Sustained Release of Celecoxib From Acrylic Intraocular Lenses (IOLs) in vitro | 1 |
| 12 | Expression of Toll-like Receptor (TLR)-4 in Equine Retina | 1 |
| 13 | Quantitative Differences in mRNA Expression of Toll-like Receptor (TLR)-2, -4, and -9 in Normal Equine Eyes and Eyes with Equine Recurrent Uveitis | 2 |
| 14 | Serum and Aqueous Humor Inflammatory Cytokine Profiles in Recurrent Uveitis | 0 |
| 15 | Retinal Imaging of the Dog and Rabbit Using a Hand–Held, High Resolution, Optical Coherence Tomography System | 1 |
| 16 | 47 | |
| 17 | Evaluation of an in vitro Model of Neutrophil Migration in the Equine Cornea | 1 |
| 18 | Cataract removal in dogs: the presurgical considerations. | 2 |
| 19 | 51 | |
| 20 | 61 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.